CEBP Meeting Calendar Targets
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by MacInnis, R. J.
Right arrow Articles by Giles, G. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by MacInnis, R. J.
Right arrow Articles by Giles, G. G.
Cancer Epidemiology Biomarkers & Prevention Vol. 12, 1417-1421, December 2003
© 2003 American Association for Cancer Research

Body Size and Composition and Prostate Cancer Risk

Robert J. MacInnis1, Dallas R. English1, Dorota M. Gertig2, John L. Hopper2 and Graham G. Giles1

1 Cancer Epidemiology Centre, The Cancer Council Victoria, Melbourne, Victoria, and 2 Centre for Genetic Epidemiology, University of Melbourne, Melbourne, Victoria, Australia

Reported associations between body measurements and the risk of prostate cancer are weak and inconsistent, possibly because some measures used do not differentiate between adipose and nonadipose tissue, body components that would theoretically have different associations with prostate cancer. Some studies have addressed this problem by estimating lean body mass from subjects’ age, height, and weight. In a prospective cohort study of men 27–75 years of age at recruitment in 1990–1994, body measurements were taken by trained interviewers. Nonadipose and adipose mass were calculated from bioelectric impedance analysis. Incident prostate cancers were ascertained by use of the population cancer registry. Altogether 16,336 men contributed 113,535 person-years and 477 cancers, of which 79 were "aggressive," to the analysis. We found no overall association between prostate cancer and any anthropometric measurement. Analysis stratified by cancer aggressiveness revealed modest associations between measures of adiposity and the risk of aggressive disease. On the basis of the WHO cut points and compared with men in the normal range of body mass index, the risk ratio for obese men was 2.2 (95% confidence interval, 1.2–4.1). For each 10-kg increase in fat mass, the risk ratio was 1.4 (95% confidence interval, 1.0–1.8). Energy imbalance may play a role in the development of aggressive prostate cancer.




This article has been cited by other articles:


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
M. D. Fesinmeyer, R. Gulati, S. Zeliadt, N. Weiss, A. R. Kristal, and R. Etzioni
Effect of Population Trends in Body Mass Index on Prostate Cancer Incidence and Mortality in the United States
Cancer Epidemiol. Biomarkers Prev., March 1, 2009; 18(3): 808 - 815.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
T. Pischon, H. Boeing, S. Weikert, N. Allen, T. Key, N. F. Johnsen, A. Tjonneland, M. T. Severinsen, K. Overvad, S. Rohrmann, et al.
Body Size and Risk of Prostate Cancer in the European Prospective Investigation into Cancer and Nutrition
Cancer Epidemiol. Biomarkers Prev., November 1, 2008; 17(11): 3252 - 3261.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
L. Zuccolo, R. Harris, D. Gunnell, S. Oliver, J. A. Lane, M. Davis, J. Donovan, D. Neal, F. Hamdy, R. Beynon, et al.
Height and Prostate Cancer Risk: A Large Nested Case-Control Study (ProtecT) and Meta-analysis
Cancer Epidemiol. Biomarkers Prev., September 1, 2008; 17(9): 2325 - 2336.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
A. W Hsing, L. C Sakoda, and S. C Chua Jr
Obesity, metabolic syndrome, and prostate cancer
Am. J. Clinical Nutrition, September 1, 2007; 86(3): 843S - 857S.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
A. J. Littman, E. White, and A. R. Kristal
Anthropometrics and Prostate Cancer Risk
Am. J. Epidemiol., June 1, 2007; 165(11): 1271 - 1279.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
D. M. Werny, T. Thompson, M. Saraiya, D. Freedman, B. J. Kottiri, R. R. German, and M. Wener
Obesity Is Negatively Associated with Prostate-Specific Antigen in U.S. Men, 2001-2004
Cancer Epidemiol. Biomarkers Prev., January 1, 2007; 16(1): 70 - 76.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
C. Rodriguez, S. J. Freedland, A. Deka, E. J. Jacobs, M. L. McCullough, A. V. Patel, M. J. Thun, and E. E. Calle
Body Mass Index, Weight Change, and Risk of Prostate Cancer in the Cancer Prevention Study II Nutrition Cohort
Cancer Epidemiol. Biomarkers Prev., January 1, 2007; 16(1): 63 - 69.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
J. S.P. Sequoia, M. E. Wright, P. McCarron, P. Pietinen, P. R. Taylor, J. Virtamo, and D. Albanes
A Prospective Investigation of Height and Prostate Cancer Risk.
Cancer Epidemiol. Biomarkers Prev., November 1, 2006; 15(11): 2174 - 2178.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
Z. Gong, M. L. Neuhouser, P. J. Goodman, D. Albanes, C. Chi, A. W. Hsing, S. M. Lippman, E. A. Platz, M. N. Pollak, I. M. Thompson, et al.
Obesity, diabetes, and risk of prostate cancer: results from the prostate cancer prevention trial.
Cancer Epidemiol. Biomarkers Prev., October 1, 2006; 15(10): 1977 - 1983.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
G. Severi, D. R. English, J. L. Hopper, and G. G. Giles
Re: Prospective studies of dairy product and calcium intakes and prostate cancer risk: a meta-analysis.
J Natl Cancer Inst, June 7, 2006; 98(11): 794 - 795.
[Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
G. Severi, H. A. Morris, R. J. MacInnis, D. R. English, W. D. Tilley, J. L. Hopper, P. Boyle, and G. G. Giles
Circulating insulin-like growth factor-I and binding protein-3 and risk of prostate cancer.
Cancer Epidemiol. Biomarkers Prev., June 1, 2006; 15(6): 1137 - 1141.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
G. Severi, H. A. Morris, R. J. MacInnis, D. R. English, W. Tilley, J. L. Hopper, P. Boyle, and G. G. Giles
Circulating Steroid Hormones and the Risk of Prostate Cancer
Cancer Epidemiol. Biomarkers Prev., January 1, 2006; 15(1): 86 - 91.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
T. N. Zhuang, L. P. Ly, R. G. Cumming, and D. J. Handelsman
Growth and Development during Early Manhood as Determinants of Prostate Size in Later Life
J. Clin. Endocrinol. Metab., November 1, 2005; 90(11): 6055 - 6063.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
R. J. MacInnis, D. R. English, J. L. Hopper, and G. G. Giles
Body Size and Composition and the Risk of Lymphohematopoietic Malignancies
J Natl Cancer Inst, August 3, 2005; 97(15): 1154 - 1157.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
R. J. MacInnis, D. R. English, D. M. Gertig, J. L. Hopper, and G. G. Giles
Body Size and Composition and Risk of Postmenopausal Breast Cancer
Cancer Epidemiol. Biomarkers Prev., December 1, 2004; 13(12): 2117 - 2125.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2003 by the American Association for Cancer Research.